CURRENT STUDIES

Learn more about our upcoming and ongoing research opportunities.

Obesity Study

A Phase II, randomized, double blind, parallel group, 46 weeks dose-finding study of BI 456906 administered once…

>> Learn More >> Apply to Volunteer

LYME Study

If you have been recently diagnosed with Lyme disease or you suspect you have Lyme disease, your…

>> Learn More >> Apply to Volunteer

FALCON Ulcerative Colitis Study

A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of study drug (GS-4875) in Subjects with…

>> Learn More >> Apply to Volunteer

Tuscany II Ulcerative Colitis Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate The Efficacy, Safety, and Pharmacokinetics of study drug…

>> Learn More >> Apply to Volunteer

U-Exceed Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects…

>> Learn More >> Apply to Volunteer

U-Excel Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects…

>> Learn More >> Apply to Volunteer

Obesity Study

A Phase II, randomized, double blind, parallel group, 46 weeks dose-finding study of BI 456906 administered once…

>> Learn More

LYME Study

If you have been recently diagnosed with Lyme disease or you suspect you have Lyme disease, your…

>> Learn More

FALCON Ulcerative Colitis Study

A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of study drug (GS-4875) in Subjects with…

>> Learn More

Tuscany II Ulcerative Colitis Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate The Efficacy, Safety, and Pharmacokinetics of study drug…

>> Learn More

U-Exceed Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects…

>> Learn More

U-Excel Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects…

>> Learn More